Friday, July 10, 2026

Intelligence · Clinical pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs 4,713
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Pipeline programs

Page 96 of 99
  1. human HER2-targeted CAR-M cells

    The First People's Hospital of Lianyungang

    Gastric Cancer

    phase 1 mab active

    1 trial
  2. human Mesenchymal Stem Cell (MSC) infusion therapy

    CytoMed Therapeutics Ltd

    Aging Well

    phase 1 mab active

    1 trial
  3. hypo-fractionated SRS

    United Therapeutics Europe Ltd

    Metastatic Cancer

    phase 1 other completed

    1 trial
  4. iC9.GD2.CAR.IL-15 T Infusion

    United Therapeutics Europe Ltd

    Lung Cancer

    phase 1 mab active

    1 trial
  5. iC9.GD2.CAR.IL-15 T-cells

    United Therapeutics Europe Ltd

    Neuroblastoma

    phase 1 mab active

    1 trial
  6. iNexin™ (0.08% aCT1)

    United Therapeutics Europe Ltd

    Dry Eye Disease

    phase 1 small molecule completed

    1 trial
  7. iTBS to the left dlPFC

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    phase 1 other completed

    1 trial
  8. idronoxil

    KAZIA THERAPEUTICS LTD

    Unspecified Adult Solid Tumor, Protocol Specific

    phase 1 small molecule completed

    1 trial
  9. illuccix 68Ga-PSMA-11 Total Body PET-CT

    Telix Innovations

    Metastatic Castration-resistant Prostate Cancer

    phase 1 small molecule active

    1 trial
  10. iloperidone (oral tablet)

    Vanda Pharmaceuticals Netherlands B.V.

    Safety and Tolerability of Iloperidone

    phase 1 small molecule completed

    1 trial
  11. imatinib mesylate

    Children's Hospital of Fudan University

    Leukemia

    phase 1 small molecule completed

    1 trial
  12. immediate release guanfacine hydrochloride

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  13. indibulin

    Alaunos Therapeutics

    Advanced Cancer

    phase 1 small molecule completed

    1 trial
  14. indibulin

    Alaunos Therapeutics

    Solid Tumors

    phase 1 small molecule active

    2 trials
  15. interceptive orthodontic treatments

    NORTHWEST BIOTHERAPEUTICS INC

    Malocclusion

    phase 1 other active

    1 trial
  16. interleukin-4 PE38KDEL cytotoxin

    NEUROCRINE BIOSCIENCES INC

    Breast Cancer

    phase 1 mab completed

    1 trial
  17. intraconazole

    ENANTA PHARMACEUTICALS INC

    NASH - Nonalcoholic Steatohepatitis

    phase 1 small molecule completed

    1 trial
  18. iridoid enriched mixed fruit beverage

    International Peace Maternity and Child Health Hospital

    Oxidative Stress

    phase 1 other completed

    1 trial
  19. itraconazole

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  20. ivosidenib (AG-120)

    Agios Netherlands B.V.

    Healthy

    phase 1 small molecule completed

    1 trial
  21. ketamine

    Summit Therapeutics

    Multiple Sclerosis

    phase 1 small molecule completed

    1 trial
  22. l-THP (l-tetrahydropalmatine)

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use

    phase 1 small molecule completed

    1 trial
  23. laquinimod

    Teva Pharma GmbH

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial
  24. limonene containing massage oil

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 1 other completed

    1 trial
  25. linvoseltamab

    Regeneron UK Limited

    Food Allergy

    phase 1 small molecule active

    1 trial
  26. lipegfilgrastim

    Teva Pharma GmbH

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial
  27. liposomal cytarabine

    Pacira Ireland Limited

    Brain and Central Nervous System Tumors

    phase 1 small molecule active

    1 trial
  28. locally manufactured adoptive cellular therapy (ACT) product

    Iovance Biotherapeutics B.V.

    Malignant Pleural Effusion

    phase 1 mab active

    1 trial
  29. lofexidine HCl

    BRIGHT MINDS BIOSCIENCES INC.

    Renally Impaired Subjects

    phase 1 small molecule completed

    1 trial
  30. lumacaftor 200 mg q12h + ivacaftor 250 mg q12h

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial
  31. lumbar puncture

    Takeda

    Crohn's Disease

    phase 1 small molecule completed

    1 trial
  32. mHealth application (custom)

    BRIGHT MINDS BIOSCIENCES INC.

    Cognitive Function Abnormal

    phase 1 other completed

    1 trial
  33. mPEG-r-crisantaspase

    Jazz Pharmaceuticals Ireland Limited

    Hematologic Malignancies

    phase 1 mab completed

    1 trial
  34. medroxyprogesterone acetate

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial
  35. mesenchymal stem cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Peripheral Vascular Disease

    phase 1 mab active

    1 trial
  36. metformin hydrochloride 500 mg tablet

    PMV Pharmaceuticals

    TP53 Y220C Mutation

    phase 1 small molecule active

    1 trial
  37. metyrapone & oxazepam

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 1 small molecule completed

    1 trial
  38. mifepristone + fluvastatin

    CORCEPT THERAPEUTICS INC

    Healthy Subjects

    phase 1 small molecule completed

    1 trial
  39. milatuzumab

    United Therapeutics Europe Ltd

    Lupus Erythematosus, Cutaneous

    phase 1 small molecule completed

    1 trial
  40. mipomersen

    IONIS PHARMACEUTICALS INC

    Healthy Volunteer

    phase 1 small molecule completed

    3 trials
  41. mipomersen sodium

    IONIS PHARMACEUTICALS INC

    Healthy

    phase 1 small molecule completed

    1 trial
  42. mitoxantrone hydrochloride

    Karyopharm Therapeutics Inc

    Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities

    phase 1 small molecule completed

    1 trial
  43. mitragynine

    BRIGHT MINDS BIOSCIENCES INC.

    Safety and Tolerability in Healthy Subjects

    phase 1 small molecule active

    1 trial
  44. monoclonal antibody M-T412

    Ultragenyx UK Limited

    Multiple Sclerosis

    phase 1 small molecule completed

    1 trial
  45. namilumab (MT203)

    Takeda

    Rheumatoid Arthritis

    phase 1 small molecule completed

    1 trial
  46. narfurine hydrochloride orally disintegrating tablets

    The First People's Hospital of Lianyungang

    Improvement of Pruritus in Hemodialysis Patients

    phase 1 small molecule active

    1 trial
  47. neratinib

    PUMA BIOTECHNOLOGY, INC.

    Healthy

    phase 1 small molecule completed

    5 trials
  48. neratinib

    PUMA BIOTECHNOLOGY, INC.

    Tumors

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.